Holen Sie sich die Stockscreener-App
1.88
8.29%
-0.17
Handel nachbörslich:
1.88
Schlusskurs vom Vortag:
$2.05
Offen:
$2.11
24-Stunden-Volumen:
298.18K
Relative Volume:
1.80
Marktkapitalisierung:
$57.90M
Einnahmen:
$1.82M
Nettoeinkommen (Verlust:
$-267.63M
KGV:
-0.0932
EPS:
-20.1639
Netto-Cashflow:
$-50.53M
1W Leistung:
-2.08%
1M Leistung:
-23.89%
6M Leistung:
-69.33%
1J Leistung:
-89.55%
1-Tages-Spanne:
$1.84
$2.3057
1-Wochen-Bereich:
$1.8036
$2.3057
52-Wochen-Spanne:
$1.8036
$23.18
Cibus Inc Stock (CBUS) Company Profile
Firmenname
Cibus Inc
Sektor
Branche
Telefon
(858) 450-0008
Adresse
6455 NANCY RIDGE DRIVE, SAN DIEGO
Vergleichen Sie CBUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.88 | 57.90M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.11B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 74.87B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.83B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 26.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
| 2023-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
Cibus Inc Aktie (CBUS) Neueste Nachrichten
Cibus Announces Leadership Transition and CEO Succession Plan - Seed World
Cibus, Inc. Announces CEO Changes -February 28, 2025 at 08:30 am EST - Marketscreener.com
Cibus Appoints Peter Beetham as Interim CEO - TipRanks
Cibus Announces Leadership Change and CEO Succession Plan - The Manila Times
Who's Taking the Helm at Cibus? Inside the Leadership Shakeup During Critical Commercialization Phase - StockTitan
Cibus director Gerhard Prante sells $2,208 in stock By Investing.com - Investing.com Australia
Levi & Korsinsky Announces an Investigation on Behalf of Cibus, Inc. (CBUS) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Cibus director Gerhard Prante sells $2,208 in stock - Investing.com India
Cibus director Gerhard Prante sells $2,380 in stock - Investing.com India
Cibus director Gerhard Prante sells $2,380 in stock By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells $2,530 in stock By Investing.com - Investing.com South Africa
Cibus director Gerhard Prante sells $2,530 in stock - Investing.com India
Cibus director Gerhard Prante sells $2,702 in stock By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells $2,702 in stock - Investing.com India
Cibus director Gerhard Prante sells $2,967 of stock By Investing.com - Investing.com Nigeria
Cibus, Inc. (NASDAQ:CBUS) Short Interest Update - MarketBeat
Cibus director Gerhard Prante sells $2,967 of stock - Investing.com
Cibus, Inc. (NASDAQ:CBUS) Sees Large Decline in Short Interest - Defense World
Cibus director Prante sells $2,875 in stock By Investing.com - Investing.com Nigeria
Cibus director Gerhard Prante sells $2,990 in stock By Investing.com - Investing.com Nigeria
Cibus director Gerhard Prante sells $2,990 in stock - Investing.com
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Cibus director Gerhard Prante sells $2,909 in stock - MSN
Cibus director Gerhard Prante sells $2,909 in stock By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells $2,817 in stock - MSN
Cibus director Prante sells $2,875 in stock - MSN
Cibus Announces Important Update to Rice Gene Editing Conversion Rates - The Manila Times
Cibus, Inc. Issues Correction on Rice Gene Editing Conversion Rates and Updates on Technological Advances - Nasdaq
Research Setback: Cibus Unable to Replicate Promising Gene Editing Results in Rice - StockTitan
Cibus director Gerhard Prante sells $5,531 in stock - MSN
Cibus director Gerhard Prante sells $2,817 in stock By Investing.com - Investing.com Australia
Cibus director Prante Gerhard sells $2,898 in stock - MSN
Cibus’ $22.6 Million Common Stock Offering - Global Legal Chronicle
Cibus director Gerhard Prante sells shares worth $2,852 By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells shares worth $2,852 - Investing.com
Cibus director Prante Gerhard sells $2,898 in stock By Investing.com - Investing.com Australia
Finanzdaten der Cibus Inc-Aktie (CBUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.13%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):